paclitaxel has been researched along with Neoplasms, Pleural in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (29.63) | 18.2507 |
| 2000's | 13 (48.15) | 29.6817 |
| 2010's | 4 (14.81) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, NQ; Colby, A; Colson, YL; de Forcrand, C; Grinstaff, MW; Liu, R; Padera, RF | 1 |
| Anand, K; Chiang, S; Duvic, M; Ensor, J; Hwu, P; Iyer, S; Miranda, R; Pingali, SR; Zu, Y | 1 |
| Fujii, K; Ishizuka, S; Saeki, S; Sakata, S; Sasaki, J; Sato, R | 1 |
| Hamaguchi, Y; Kitano, T; Maeda, S; Matsumoto, I; Mizumaki, K; Oishi, K; Saito, D; Takehara, K; Yoshida, S | 1 |
| Atanaskova Mesinkovska, N; Conic, RZ; Kiracofe, EA; Vidimos, AT | 1 |
| Dougherty, M; Loiselle, A; Munzer, K; Patel, MB; Williams, P | 1 |
| Heinrich, G; Loibl, S; Müller, L; Murmann, C; Nekljudova, V; Schwedler, K; von Minckwitz, G; Warm, M | 1 |
| Chen, JR; Tzen, CY; Yang, YC | 1 |
| Hanibuchi, M; Hirano, H; Ito, M; Maeda, H; Nakagawa, M; Okumura, Y; Sawabata, Y; Takeda, S; Uematsu, K | 1 |
| Arvin-Berod, C; Davy, N; Perrot, E; Poubeau, P | 1 |
| Matsumoto, I; Ohta, Y; Shimizu, Y; Watanabe, G | 1 |
| Ceron, L; Paccagnella, A; Pagan, V; Pizzi, G | 1 |
| Suzuki, M | 1 |
| Debruyne, C; Galdermans, D; Giaccone, G; Groen, H; Pennucci, MC; Pinson, P; Postmus, PE; van Breukelen, F; van Glabbeke, M; van Marck, E; van Meerbeeck, J; van Zandwijk, N | 1 |
| Du Bois, A; Hecker, D; Köhler, G; Lisboa, B; Lück, HJ; Thomssen, C; Untch, M | 1 |
| Cook, J; Goldspiel, B; Hahn, SM; Herscher, LL; Kroog, G; Liebmann, J; Mitchell, JB; Pass, H; Temeck, B | 1 |
| Chahinian, AP; Gluck, H; Holland, JF; Mandeli, JP; Naim, H; Teirstein, AS | 1 |
| Bastert, G; Diel, IJ; Emig, R; Meyberg, G; Sinn, HP; Solomayer, EF; Wallwiener, D | 1 |
| Aoki, T; Kaise, H; Koyanagi, Y; Kusama, M; Matsunaga, T; Nakamura, Y; Nakayama, S; Yoneda, K | 1 |
| Bueno, R | 1 |
| Grondin, SC; Sugarbaker, DJ | 1 |
| Atassi, G; Guilbaud, N; Jan, M; Kraus-Berthier, L; Naze, M; Pierré, A | 1 |
| Halme, M; Jekunen, A; Kivisaari, L; Knuuttila, A; Linnainmaa, K; Mali, P; Mattson, K; Ollikainen, T | 1 |
| Casadio, C; Cianci, R; Maggi, G; Rena, O; Ruffini, E | 1 |
| Ganser, A; Grünwald, V; Karstens, JH; Kuske, M; Le Blanc, S; Schöffski, P; Weihkopf, T | 1 |
| Riviere, A | 1 |
| Abratt, RP; Chasen, MR; Cronje, N; Fourie, L; Hacking, D; McMichael, G; Rapoport, BL; Vorobiof, DA | 1 |
3 review(s) available for paclitaxel and Neoplasms, Pleural
| Article | Year |
|---|---|
T-cell lymphoma secondary to checkpoint inhibitor therapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Humans; Immunotherapy; Lymphoma, T-Cell; Male; Neoplasms, Second Primary; Paclitaxel; Pleural Neoplasms; Prognosis; Urinary Bladder Neoplasms | 2020 |
Localized pleural malignant mesothelioma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Male; Mesothelioma; Neoplasm Recurrence, Local; Paclitaxel; Pleural Neoplasms; Radiography, Thoracic; Tomography, X-Ray Computed | 2003 |
[Does treatment for malignant pleural mesothelioma exist?].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Drug Therapy, Combination; Female; Gemcitabine; Glutamates; Guanine; Humans; Immunotherapy; Interferons; Male; Mesothelioma; Middle Aged; Mitomycin; Multivariate Analysis; Paclitaxel; Palliative Care; Pemetrexed; Pleural Neoplasms; Pneumonectomy; Postoperative Care; Radiotherapy Dosage; Time Factors | 2001 |
6 trial(s) available for paclitaxel and Neoplasms, Pleural
| Article | Year |
|---|---|
Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Paclitaxel; Pleural Neoplasms; Survival Rate; Treatment Outcome | 2009 |
Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Humans; Male; Mesothelioma; Middle Aged; Paclitaxel; Pleural Neoplasms | 1996 |
Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Pleural Neoplasms; Treatment Outcome; Ventricular Function, Left | 1997 |
Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Paclitaxel; Pleural Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1998 |
Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility study.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Feasibility Studies; Female; Humans; Irinotecan; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Pleural Neoplasms; Survival Rate; Taxoids; Treatment Outcome | 2000 |
Malignant pleural mesothelioma: a phase II trial with docetaxel.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma; Docetaxel; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Mesothelioma; Middle Aged; Paclitaxel; Pleural Neoplasms; Survival Rate; Taxoids | 2002 |
18 other study(ies) available for paclitaxel and Neoplasms, Pleural
| Article | Year |
|---|---|
Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts.
Topics: Animals; Cell Line, Tumor; Combined Modality Therapy; Cytoreduction Surgical Procedures; Disease Models, Animal; Disease Progression; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Nanoparticles; Paclitaxel; Pleural Neoplasms; Pneumonectomy; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Carboplatin; Carcinoma; Drug Administration Schedule; Humans; Lung Neoplasms; Lymphatic Metastasis; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Pleural Neoplasms; Proteinuria; Tomography, X-Ray Computed; Treatment Outcome; Withholding Treatment | 2017 |
Angiosarcoma-related pneumohemothorax treated with intrapleural paclitaxel administration and pleurodesis with OK-432.
Topics: Aged; Antineoplastic Agents; Fatal Outcome; Hemangiosarcoma; Hemothorax; Humans; Male; Paclitaxel; Picibanil; Pleural Neoplasms; Pleurodesis; Pneumothorax; Recurrence; Skin Neoplasms | 2018 |
Treatment of invasive squamous cell carcinomas in an open Clagett window.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Debridement; Empyema; Female; Fluorouracil; Humans; Neoplasm Invasiveness; Paclitaxel; Pleural Cavity; Pleural Neoplasms; Thoracostomy | 2015 |
Pleural Myiasis Associated With Pleural Angiosarcoma.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Disease Management; Empyema, Pleural; Hemangiosarcoma; Humans; Hydropneumothorax; Male; Myiasis; Paclitaxel; Pleural Cavity; Pleural Neoplasms; Thoracic Surgery, Video-Assisted; Thoracostomy | 2016 |
Metronomic paclitaxel and thalidomide for rapidly metastatic primary vulvar malignant rhabdoid tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Paclitaxel; Pleural Neoplasms; Rhabdoid Tumor; Thalidomide; Vulvar Neoplasms; Young Adult | 2009 |
[Chemotherapy with paclitaxel for lung metastases of cystic adenoid carcinoma. A case report and review of the literature].
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Adenoid Cystic; Female; Humans; Lung Neoplasms; Paclitaxel; Pleural Neoplasms; Salivary Gland Neoplasms; Treatment Outcome | 2003 |
Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pleural Effusion; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurisy; Time Factors; Treatment Outcome | 2006 |
5-year prospective results of trimodality treatment for malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Mesothelioma; Middle Aged; Paclitaxel; Pleural Neoplasms; Pneumonectomy; Prospective Studies; Time Factors; Treatment Outcome | 2006 |
[A patient with advanced breast cancer refractory to chemotherapy accompanied by carcinomatous pleurisy and multiple bone metastasis that responded to combination therapy with high-dose toremifene and docetaxel].
Topics: Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Paclitaxel; Pleural Effusion, Malignant; Pleural Neoplasms; Quality of Life; Remission Induction; Taxoids; Toremifene | 2007 |
Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fibrosarcoma; Humans; Mesothelioma; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Pleural Neoplasms; Sarcoma; Suramin; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
[Complete remission after salvage chemotherapy in metastatic breast carcinoma after failure of induction cycles of planned high dosage chemotherapy with stem cell support].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Mastectomy, Segmental; Neoplasm Staging; Paclitaxel; Pleural Neoplasms; Remission Induction; Salvage Therapy | 1998 |
[A breast cancer patient with docetaxel-resistant pleural recurrence with remarkable response to doxifluridine and cyclophosphamide].
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cranial Irradiation; Cyclophosphamide; Docetaxel; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pleural Neoplasms; Quality of Life; Taxoids | 1999 |
Mesothelioma clinical presentation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Cisplatin; Combined Modality Therapy; Follow-Up Studies; Humans; Male; Mesothelioma; Middle Aged; Paclitaxel; Pleural Neoplasms; Pneumonectomy; Radiation-Sensitizing Agents; Thoracic Surgery, Video-Assisted | 1999 |
Pleuropneumonectomy in the treatment of malignant pleural mesothelioma.
Topics: Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Intraoperative Care; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Selection; Pleura; Pleural Neoplasms; Pneumonectomy; Postoperative Complications; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Survival Rate; Treatment Outcome | 1999 |
Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Doxorubicin; Ellipticines; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Nude; Neoplasm Metastasis; Paclitaxel; Pleural Neoplasms; Topotecan; Transplantation, Heterologous; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2000 |
Trimodality management of malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Mesothelioma; Middle Aged; Paclitaxel; Pleural Neoplasms; Pneumonectomy; Radiation Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome | 2001 |
Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatin.
Topics: Adult; Ameloblastoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Infusions, Intravenous; Jaw Neoplasms; Lung Neoplasms; Paclitaxel; Pleural Neoplasms; Salvage Therapy; Treatment Outcome | 2001 |